Valuation: ResMed Inc.

Market Cap 35.56B 192B 31.85B 29.38B 26.59B 49.72B 3,386B 50.52B 351B 140B 1,772B 133B 131B 5,613B P/E 2027 *
21.7x
P/E 2028 * 19.7x
Enterprise Value 34.56B 187B 30.95B 28.55B 25.84B 48.32B 3,291B 49.1B 341B 136B 1,722B 130B 127B 5,455B EV / Sales 2027 *
5.95x
EV / Sales 2028 * 5.5x
Free-Float
74.65%
Yield 2027 *
1.06%
Yield 2028 * 1.15%
1 day+20.76%
Current month+20.76%
1 month+20.76%
3 months+20.76%
6 months+5.80%
Current year-11.93%
1 month 238.41
Extreme 238.41
294.47
Current year 238.41
Extreme 238.41
357.02
1 year 238.41
Extreme 238.41
357.02
3 years 187.67
Extreme 187.67
397
5 years 183.79
Extreme 183.79
397
10 years 144.25
Extreme 144.25
397
Manager TitleAgeSince
Chief Executive Officer 54 01/03/2013
Director of Finance/CFO 41 04/05/2026
Chief Tech/Sci/R&D Officer - 01/02/2024
Director TitleAgeSince
Director/Board Member 78 01/01/2005
Chairman 54 25/01/2023
Chairman 84 01/06/1989
Change 5-day change 1-year change 3-year change Capi.($)
+20.76%0.00% - - 35.18B
+0.71%+4.82%+27.02%+64.39% 260B
+1.24%+3.15%+10.73%+26.13% 165B
+1.03%+1.11%-16.52%+73.28% 154B
+0.61%-7.22%-57.44%-13.79% 61.49B
+2.90%+4.83%+14.21%+53.04% 52.9B
+0.70%+2.71%-13.09%-6.48% 52.84B
-2.35%-3.79%+8.26%+63.75% 51.46B
-0.18%+4.18%+26.50%+76.27% 51.16B
+0.67%+5.37%+39.77%+96.14% 46.85B
Average +2.61%+1.68%+4.38%+48.08% 99.52B
Weighted average by Cap. +1.51%+2.42%+7.18%+50.97%

Financials

2027 *2028 *
Net sales 5.8B 31.41B 5.2B 4.8B 4.34B 8.11B 553B 8.25B 57.21B 22.82B 289B 21.78B 21.31B 916B 6.18B 33.44B 5.53B 5.11B 4.62B 8.64B 588B 8.78B 60.91B 24.3B 308B 23.19B 22.69B 975B
Net income 1.64B 8.88B 1.47B 1.36B 1.23B 2.29B 156B 2.33B 16.17B 6.45B 81.76B 6.16B 6.03B 259B 1.78B 9.64B 1.6B 1.47B 1.33B 2.49B 170B 2.53B 17.56B 7.01B 88.78B 6.69B 6.54B 281B
Net Debt -1B -5.42B -898M -828M -749M -1.4B -95.43B -1.42B -9.88B -3.94B -49.94B -3.76B -3.68B -158B -1.56B -8.42B -1.39B -1.29B -1.16B -2.18B -148B -2.21B -15.34B -6.12B -77.53B -5.84B -5.71B -246B
Projected Income Statement - Annual - ResMed Inc.
Logo ResMed Inc.
ResMed, Inc. specializes in designing, manufacturing and marketing respiratory disorders diagnosis, treatments and management (primarily sleep respiratory disorders). Net sales break down by family of products as follows: - medical devices (51.2%); - masks (36.9%); - software as a service (11.9%): residential care management software solutions. At the end of June 2026, the group had 9 production sites located in the United States (4), Australia, China, Singapore, Malaysia and France. The United States accounts for 63% of net sales.
Employees
11,370
Trader
Investor
Global
Quality
ESG MSCI
-
MarketScreener Ratings - ResMed Inc.
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
20
Last Close Price
252.83USD
Average target price
251.52USD
Spread / Average Target
-0.52%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - ResMed Inc.